Global Soluciones Financieras has completed a capital increase
Global Soluciones Financieras S.A. (GSF) has completed a capital increase, which includes the entry of new investors, in order to complete its financial restructuring.
Global Soluciones Financieras, through its subsidiaries, provides financing services to the automotive industry in Chile. It offers automotive credit services, which include instant, conventional and smart credits and vehicle assistance services; financial leasing services; and insurance products, such as unemployment, general and life, car and liability and disability. The company was incorporated in 2010 and is based in Las Condes, Chile.
Oaklins’ team in Chile acted as the exclusive financial advisor and placement agent to GSF in the financial restructuring, which involved a capital increase of US$21.5 million.


Contáctese con el equipo de la transacción
Transacciones relacionadas
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Aprenda másBuydepa has completed an IPO through ScaleX
Buydepa S.p.A. has successfully raised US$3.1 million (CLP3 billion) through its stock market debut on ScaleX (Santiago Venture Exchange). The company placed 12% of its shares through a capital increase, with subscriptions from a local institutional investor and a broad base of high-net-worth qualified investors.
Aprenda másDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Aprenda más